학술논문
Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial
Document Type
Article
Author
Matthay, Michael A; Calfee, Carolyn S; Zhuo, Hanjing; Thompson, B Taylor; Wilson, Jennifer G; Levitt, Joseph E; Rogers, Angela J; Gotts, Jeffrey E; Wiener-Kronish, Jeanine P; Bajwa, Ednan K; Donahoe, Michael P; McVerry, Bryan J; Ortiz, Luis A; Exline, Matthew; Christman, John W; Abbott, Jason; Delucchi, Kevin L; Caballero, Lizette; McMillan, Melanie; McKenna, David H; Liu, Kathleen D
Source
In The Lancet Respiratory Medicine February 2019 7(2):154-162
Subject
Language
ISSN
2213-2600